On June 30, 2021, USC Alzheimer’s Therapeutic Research Institute’s Michael Rafii, MD, PhD, and Alzheimer’s Clinical Trial Consortium (ACTC) colleague Jason Karlawish, MD, met for a discussion of Karlawish’s recent bookThe Problem of Alzheimer’s: How Science, Culture, and Politics Turned a Rare Disease Into a Crisis and What We Can Do About It.
There was a great discussion of how Mild Cognitive Impairment came to exist, as well as a frank discussion of how the first disease-modifying treatment approved by the FDA came to pass.
Dr. Rafii is an associate professor of clinical neurology and medical director of the Alzheimer’s Therapeutic Research Institute at the Keck School of Medicine of USC. Dr. Karlawish is a professor of medicine, medical ethics and health policy, and neurology at the University of Pennsylvania and co-director of the Penn Memory Center
Watch a recording of the event, and let us know if you’d like to be alerted about future events!
